# Pathological mechanisms and clinical research progress of endothelial dysfunction

## TL;DR

This review summarizes the causes, effects, and treatments of endothelial dysfunction, a key factor in cardiovascular and metabolic diseases.

## Contribution

The paper provides an updated and comprehensive overview of endothelial dysfunction mechanisms and therapies.

## Key findings

- Endothelial dysfunction is linked to diabetes, atherosclerosis, and cerebrovascular disorders.
- Emerging therapies include stem cell and gene therapy for treating endothelial dysfunction.
- Biomarkers for endothelial dysfunction have clinical significance but also limitations.

## Abstract

Endothelial dysfunction (ED) has emerged as a critical pathological contributor to a variety of cardiovascular and metabolic disorders, garnering increasing attention in recent years. This review presents a comprehensive overview of ED, commencing with its definition and broadened criteria. It delves into the molecular mechanisms underlying ED, including reduced nitric oxide availability, oxidative stress, inflammatory responses, apoptosis of endothelial cells, and the emerging concept of endothelial-mesenchymal transition. Furthermore, we investigate the association between ED and multiple conditions, such as diabetes, atherosclerosis, cerebrovascular disorders, and obstructive sleep apnea, drawing on finding from recent clinical investigations. The review highlights the clinical significance and limitations of various biomarkers associated with ED. Moreover, we explore contemporary pharmacological treatment modalities and pioneering therapeutic strategies to alleviate ED, including small molecule agents, stem cell therapy, and gene therapy. By integrating the most recent discoveries from both fundamental and clinical research, this review aims to establish a robust theoretical framework and provide practical guidelines for the diagnosis, prevention, and management of ED.